Efficacy of green jackfruit flour as a medical nutrition therapy replacing rice or wheat in patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled study
Authors:
Open Access
- 14 June 2021
- journal article
- research article
- Published by Springer Nature in Nutrition & Diabetes
- Vol. 11 (1) , 1-6
Abstract
Background/Objectives: Medical nutrition therapy along with pharmacological interventions as a multidisciplinary approach is required to treat type 2 diabetes mellitus (T2DM). This study evaluated the efficacy of Jackfruit365™ green jackfruit flour as an integral part of daily meal in patients with T2DM. Subjects/Methods: This was a randomized, double-blind, placebo-controlled study conducted between May 2019 and February 2020. Patients of either sex aged ≥18 to ≤60 years with a diagnosis of T2DM for >1 year receiving oral antihyperglycemic agents were randomized (1:1) to receive either jackfruit flour 30 g/day (Group A) or placebo flour (Group B) (breakfast and dinner) daily for 12 weeks replacing an equal volume of rice or wheat flour. The primary endpoint was a mean change in glycosylated hemoglobin (HbA1c). Other endpoints were mean changes in fasting plasma glucose (FPG), postprandial plasma glucose (PPG), lipid profile, and body weight. The independent t-test was used to compare changes between the groups. Results: A total of 40 patients were enrolled (n = 20 each). A significantly higher reduction in HbA1c was observed in Group A compared to Group B from baseline to week 12 [−2.73 mmol/mol (−0.25%) vs. 0.22 mmol/mol (0.02%), p = 0.006]. The mean change in FPG and PPG was significantly higher in Group A than that of Group B (p = 0.043 and p = 0.001). The continuous glucose monitoring showed decreasing mean blood glucose in 7 days of administration of jackfruit flour meal. Conclusion: Patients from Group A had a significantly higher reduction in HbA1c, FPG, and PPG than Group B demonstrating the efficacy of jackfruit flour in glycemic control as medical nutrition therapy replacing an equal volume of rice or wheat flour in daily meal. Clinical trial registry: CTRI/2019/05/019417.Keywords
Funding Information
- Diet Fibre 365 Food Products private limited, India
This publication has 17 references indexed in Scilit:
- Can the Mediterranean diet lower HbA1c in type 2 diabetes? Results from a randomized cross-over studyNutrition, Metabolism and Cardiovascular Diseases, 2011
- Evaluation of the hypoglycemic and hypolipidemic effects of an ethylacetate fraction of Artocarpus heterophyllus (jak) leaves in streptozotocin-induced diabetic ratsPharmacognosy Magazine, 2010
- Structure–Activity Relationship of Prenyl‐Substituted Polyphenols from Artocarpus heterophyllus as Inhibitors of Melanin Biosynthesis in Cultured Melanoma CellsChemistry & Biodiversity, 2007
- Hypoglycaemic action of the flavonoid fraction of Artocarpus heterophyllus leafAfrican Journal of Traditional, Complementary and Alternative Medicines, 2006
- Chemical and flavour changes in jackfruit (Artocarpus heterophyllus Lam.) cultivar J3 during ripeningPostharvest Biology and Technology, 2006
- Screening of traditional antidiabetic medicinal plants of mauritius for possible α‐amylase inhibitory effects in vitroPhytotherapy Research, 2006
- Antihyperglycaemic and Antioxidant Effect of Rutin, a Polyphenolic Flavonoid, in Streptozotocin‐Induced Diabetic Wistar RatsBasic & Clinical Pharmacology & Toxicology, 2006
- Analysis of carotenoids in ripe jackfruit (Artocarpus heterophyllus) kernel and study of their bioconversion in ratsJournal of the Science of Food and Agriculture, 2004
- Effect of Artocarpus heterophyllus and Asteracanthus longifolia on glucose tolerance in normal human subjects and in maturity-onset diabetic patientsJournal of Ethnopharmacology, 1991
- Wood phenolics in the chemotaxonomy of the moraceaePhytochemistry, 1972